Immunogen, Inc. (IMGN) Reports Q4 EPS Loss of $0.23
Get Alerts IMGN Hot Sheet
Price: $31.25 --0%
EPS Growth %: +100.0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
DSGN, ATRA, CRVS, More
EPS Growth %: +100.0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
DSGN, ATRA, CRVS, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $4.41 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Trends (CTRN) Misses Q4 EPS by 27c, Misses on Revenue; Offers Guidance
- Alpine Immune Sciences (ALPN) Reports FY Loss of $0.64
- Comtech Telecom (CMTL) Misses Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!